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Abstract. In this study we have investigated the role of 
oxygen delivery and of classic second messengers on 
erythropoietin production by the isolated perfused rat 
kidney. We found that the rat kidney was capable of de 
novo synthesis of erythropoietin. The erythropoietin pro- 
duction rate was inversely related to the oxygen pressure 
in the perfusate and increased from 0.17 to 1.85U 
erythropoietin h -1 g kidney -z when arterial PO2 was 
lowered from 500 mmHg to 30 mmHg. Addition of for- 
skolin (10 gM) and 8-bromo-cGMP (100 gM) to the per- 
fusate elicited significant effects on the renal vascular e- 
sistance, but had no significant effect on erythropoietin 
production. Hypoxia-induced erythropoietin formation, 
however, was blocked by calmidazolium (1gM) and W-7 
(10 lxM), two structurally different putative calmodulin 
antagonists. Calmidazolium and W-7 had no effect on 
other functional parameters of the isolated perfused rat 
kidney such as flow rate, glomerular filtration rate or so- 
dium reabsorption. Our findings uggest that the oxygen- 
sensing mechanism that controls renal erythropoietin 
production is primarily located in the kidney itself. A cap 
cium/calmodulin-dependent cellular reaction could be 
involved in the signal transduction process. 
Key words: Isolated perfused kidney - Radioim- 
munoassay - Hypoxia - Renal oxygen sensing - 
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Introduction 
It is accepted that the kidneys are the main site of 
erythropoietin (EPO) synthesis in the organism [12, 14]. 
Within the kidneys EPO is most likely produced by corti- 
cal peritubular cells, depending on the oxygen supply to 
the kidneys [15, 18]. Recently, evidence was provided that 
EPO production is regulated at least in part by the rate 
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of gene transcription [2, 3, 25, 26]. However, it is still sub- 
ject to discussion whether the sensing of oxygen supply 
and its transduction i to adequate EPO synthesis are per- 
formed extrarenally or in the kidney itself [1]. A strong 
argument for an oxygen-sensing function of the kidney 
would be the demonstration that the isolated kidney is ca- 
pable of producing EPO in an oxygen-dependent manner, 
as is known to occur in the intact organism. In fact, it has 
been reported that isolated perfused kidneys release more 
EPO when the oxygen supply is lowered [7, 9, 16, 28]. In 
those studies the amount of EPO released from isolated 
kidneys was determined indirectly either by measuring 
EPO dependent 59Fe incorporation into red blood cells 
[7, 9, 28] or by determination f the proliferative activity 
of the erythron [16]. Moreover, those experiments were 
partly performed in kidneys isolated from hypoxic ani- 
mals, a fact that makes it difficult to distinguish whether 
EPO formation had been really induced or had merely 
been modulated uring ex vivo perfusion [7]. A major ar- 
gument against an essential "oxygen sensing" by the kid- 
ney is that a severe reduction of renal oxygen supply by 
selective reduction of renal perfusion only causes a slight 
increase of EPO formation while the same decrease of 
oxygen supply by a reduction of the systemic oxygen 
transport capacity leads to an exponentially increasing 
EPO production [20]. 
In view of these conflicting findings it seemed reason- 
able to examine whether EPO production can be repro- 
ducibly induced by oxygen depletion in isolated perfused 
kidneys, taken from normoxic animals. To this end isolat- 
ed kidneys were perfused at constant pressure in a recir- 
culatory system containing red cells. To improve the func- 
tional conservation of the preparation the perfusate was 
continuously dialysed during the experiments. The 
amount of EPO released into the perfusion medium was 
determined by using a sensitive and specific radioim- 
munoassay [5]. 
If EPO formation could really be induced in isolated 
perfused kidneys taken from normoxic animals by oxygen 
depletion, then this model could be used to investigate 
the principles of the signal transduction that link EPO 
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production to oxygen delivery. Even though the oxygen- 
sensing mechanism underlying EPO formation remains 
rather elusive at the moment, it is conceivable that EPO 
synthesis might be controlled by intracellular release of 
second-messenger molecules. Therefore, as a first ap- 
proach, we have examined the effects of the classic sec- 
ond messengers such as cyclic AMP, cyclic GMP and cal- 
cium/calmodulin o  EPO production by the isolated per- 
fused rat kidney. 
Analytical methods 
Determination of EPO. Before assay for EPO, perfusate samples were 
concentrated 5 to 7-fold by ultrafiltration through low-absorption YM 
membranes with a 30-kDa molecular mass cutoff and a measured recov- 
ery for ~25I-EPO of approximately 90~ (Centricon microconcen- 
trators, Amicon, USA). EPO was measured by radioimmunoassay as 
described [5] using a rabbit antiserum raised against recombinant hu- 
man EPO and iodinated recombinant EPO (Amersham Lab., England) 
as tracer. A serum pool obtained from hypoxic rats was used as standard 
after previous determination f the EPO content by in vivo bioassay [5]. 
Materials and methods 
Determination of sodium and potassium. Sodium and potassium were 
analysed by flame photometry (Instrumentation Laboratory 943). 
Male SIV strain rats (250-350 gbody weight), which had free access to 
commercial chow and tap water before the experiments, were used 
throughout. According to the technique described by Schurek and Alt 
[24], kidney perfusion was performed as follows: rats were anaesthetiz- 
ed by intraperitoneal injection of 150 mg/kg 5-ethyl-5 (l'-methylprop- 
yl)-2-thiobarbituric acid (Inactin, Byk Gulden, Konstanz, FRG). During 
preparation, respiration was maintained using a Harvard respirator (75 
strokes/rain, stroke volume 2ml, 25~ 02). Following abdominal 
midline incision, the right ureter was cannulated with a polypropylene 
tube (PP-10) connected toa larger polyethylene catheter (PE-50). After 
intravenous heparin injection (2 U/g body weight Liquemin, Roche, Ba- 
sel, Switzerland) via a catheter in the jugular vein, the kidney was plac- 
ed in a metal chamber fixed at a micropuncture table. The arterial 
branches of the abdominal aorta were ligated and a double-barreled 
cannula was inserted into the aorta and placed at the origin of the renal 
artery. To avoid renal ischaemia, perfusion was started in situ with an 
initial flow rate of 8 ml/min. The kidney was isolated from the animal 
and, about 10 rain later, perfusion at constant pressure was established. 
The effective perfusion pressure was monitored through the inner part 
of the cannula (Statham transducer P10EZ) and held constant at 
100 mmHg by means of a feedback-regulated p ristaltic pump. The per- 
fusion medium consisted of a Krebs-Henseleit physiological saline con- 
taining a/1 physiological mino acids in concentrations between 0.2 mM 
and 2.0 raM, 8.7 mM glucose, 0.3 mM pyruvate, 2.0raM L-lactate, 
1.0 mM 2-oxoglutarate, 1.0 mM L-malate and 6.0 mM urea. Thyroid 
hormone (150ng/i00ml), [Lys ] vasopressin (lmU/100ml) and 
polyfructosan (1g/l) were also added. Ampicillin and flucloxacillin 
(3 mg/lOOml each) were used as antibiotics. Moreover, the perfusate 
contained 2 g/100 ml bovine serum albumin and a 9O7o - 11~ fraction 
of three times freshly washed human erythrocytes. An in-line filter 
(8 gm pore size) was used during the preperfusion period, before 
erythrocytes were added, to remove small particles from the circulation. 
The perfusate, which was thermostated to 37 ~ was taken from a reser- 
voir (200-220 ml). The experiments were performed in a recirculatory 
perfusion system. To this end the renal vein was catheterized with a met- 
al cannula nd the venous effluent was drained back into the reservoir. 
To improve the functional conservation f the preparation the perfusion 
medium was continuously dialysed against a20-fold volume of protein- 
free Krebs-Henseleit solution. Oxygen delivery to the kidney was adjust- 
ed by equilibrating the dialysate with gas mixtures containing various 
amounts of oxygen. Oxygen partial pressure was measured in the ve- 
nous outflow or in an arterial bypass using an in-line Clark type 
O2-electrode (Eschweiler, KieI, FRG), Before and after each experi- 
ment, the 0 2 electrode was calibrated with nitrogen and 100% oxygen, 
respectively. The perfusion flow rate was obtained from the pump revo- 
lutions. Perfusion pressure, flow rate, and arterial and venous PO 2 in 
the perfusate were continuously monitored by a potentiometric ecorder 
(Kipp & Zonen, Delft, Netherlands). EPO was assayed in aliquots 
drawn from the perfusion medium at 30-rain intervals. To obtain steady- 
state conditions the tested rugs, dissolved in freshly prepared perfusion 
medium, were continuously infused into the arterial limb of the circula- 
tion directly in front of the kidney. Addition of the compounds was nor- 
mally started about 30 min after the onset of perfusion and maintained 
for a l-h period. A flow-proportional infusion rate of 207o f the perfu- 
sion flow was adjusted by using a peristaltic pump (2132 Microperpex, 
LKB, Bomma, Sweden). 
Determination of glomerular filtration rate. The glomerular filtration 
rate was obtained from polyfructosan (Laevosan, Linz, Austria) clear- 
ance. Polyfructosan was measured after acid hydrolysis by a 
phosphohexose i omerase reaction [23]. 
Calculation of oxygen consumption. Oxygen consumption of the kid- 
neys was calculated from the arterio-venousPO 2 difference of physical- 
ly dissolved and haemoglobin-bound oxygen and the perfusion flow 
rate. Concentrations of dissolved oxygen were calculated from the arte- 
rial and venous PO 2 values using the absorption coefficient for oxygen 
(aO 2 = 0.0227) in physiological saline at 37 ~ For determination f 
haemoglobin-bound oxygen an oxygen-binding curve was made for ev- 
ery perfusate by tonometry (Instrumentation Laboratory 237). Haemo- 
globin concentrations were measured spectropbotometrically (CO-Ox- 
imeter, Instrumentation Laboratory 282). Arterio-venous differences of
haemoglobin-bound oxygen were then calculated from the oxygen-bind- 
ing curves, the haemoglobin concentrations and the respective arterial 
and venous PO 2 values. 
Materials. Pyruvate and the test kit for polyfructosan determination 
were obtained from Boehringer, Mannheim, FRG. Ampicillin and 
flucloxacillin were from Beecham, Bern, Switzerland. Glutamate, urea, 
and 2-oxoglutarate w re provided by Merck, Darmstadt, FRG. L-Maiic 
acid and L-lactate as sodium salts were obtained from Serva, Heidel- 
berg, FRG. Bovine serum albumin, cyclic 8-bromo-GMP and N- 
(6-aminohexyl)-5-chloro-l-naphthalenesulphonamide (W-7) wer from 
Sigma International. Thyroid hormone was supplied by Henning, Ber- 
lin, and L-amino acids by Braan/Melsungen, FRG (Aminoplasmai 
paed. free of carbon hydrates). Polyfructosan was purchased from 
Laevosan, Linz, Austria, and [LysS]vasopressin from Sandoz, Basel, 
Switzerland. Forskolin was obtained from Calbiochem, Luzern, Swit- 
zerland, and calmidazolium from Janssen, Olen, Belgium. 
Statistics. Student's t-test was used for comparison of groups and anal- 
ysis of variance to determine l vels of significance. P <0.05 was consid- 
ered significant. 
Results 
EPO release from kidneys perfused at PO z values of 
500mmHg and 120mmHg is shown in Fig. l a. At 
500 mmHg the amount of EPO released by the kidneys 
rose almost linearly during the first 3 h of perfusion and 
reached aconstant level further on. For this condition the 
EPO production rate was caiculated to be 0.I7_+0.02 U
h -1 g kidney -1 (mean_+SEM, n -- 5). When perfused at 
an oxygen pressure of 120 mmHg, EPO release signifi- 
cantly increased 60-90 min after the onset of perfusion 
(P<0.05). After 3.5 h of perfusion the amount of EPO 
present in the perfusate remained constant. For the phase 
of linear increase (between 90 rain and 150 min) the EPO 
production rate was calculated to be 1.2__0.1 U h- lg 
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Table 1. Functional parameters of isolated perfused rat kidneys a
Parameter PO 2 Value after 
(mmHg) 
30 min 90 rain 150 min 
Perfusion flow rate 500 11 +-2 12 _+2 11 +-2 
(mlmin - lg  -1) 120 12 _+1 14 +-2 15 +2 
GFR (mlmin-~ g-1) 500 1.3+0.1 1.2+-0.1 1.1 +0.1 
120 1.1 +-0.1 1.0+-0.1 0.8+-0.1 
Na reabsorption 500 87 +2 73 +6 62 +-4 
(% of tubular load) 120 82 +4 65 -+6 56 +-6 
QO 2 500 6.4_+1.2 6.5+-1.0 5.0+-1.4 
(~tmol min -  ~ g - l )  120 6.2+0.9 4.8_+0.9 3.9+-0.6 
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Fig. 1. Time-dependent erythI:opoietin (EPO) production by isolated 
rat kidneys (A) perfused at arterial PO 2 values of 500 mmHg ( O ) and 
120mmHg (e )  and (B) perfused first at 500mmHg (O) and subse- 
quently at 120 mmHg (e) .  A Increase of erythropoietin release from 
kidneys perfused at PO 2 values of 120 mmHg was statistically signifi- 
cant from 60 min after the onset of perfusion (P<0.05). EPO forma- 
tion rates were calculated for the phase of linear increase. Values are 
means + SEM, n = 5. B Arterial PO 2 was lowered to 120 mmHg 50 min 
after the onset of perfusion (arrow). Note the time lag of 60 -90  min 
between decrease of oxygen supply and significant increase of EPO re- 
lease (P< 0.05). EPO formation rate (mean+_SEM, n = 5) was calculat- 
ed for the phase of linear increase 
kidney -1 (mean+SEM, n = 5). To test the possibility 
that the low EPO formation rate of 0.17+0.02 U h -1 g 
kidney-1 at high oxygen pressure might not result from 
oxygen-dependent regulation of EPO synthesis, but rath- 
er from a toxic effect of the high oxygen pressure on the 
mechanisms controlling EPO formation, kidney perfu- 
sion was started at an arterial P02 of 500 mmHg, which 
was lowered to 120 mmHg 50 min after the onset of per- 
fusion (Fig. 1 b). Again, reduction of oxygen pressure was 
followed by a significantly (P< 0.05) increased EPO for- 
mation rate of 1.2 U h- lg  kidney -1 with a delay o f  
60-90  min. In further experiments PO2 was lowered 
from 500 mmHg to 300 mmHg and from 500 mmHg to 
30 mmHg 50 min after the onset of perfusion. As in the 
experiments hown in Fig. l b, EPO release increased 
60-90 min after reduction of the renal oxygen supply. 
The relationship of EPO production rates to the PO2 
values in the perfusate is shown in Fig. 2. Apparently, 
EPO production rates and PO 2 values were negatively 
correlated in an almost linear fashion. The effects of the 
oxygen tension in the perfusate on flow rate, glomerular 
filtration rate, sodium reabsorption and oxygen con- 
sumption of the isolated perfused rat kidney are summa- 
a Functional parameters of kidneys perfused at arterial PO 2 values of 
500mmHg and 120mmHg, respectively. Values are expressed as 
means _+ SEM, n = 5; GFR, glomerular filtration rate; QO2, renal oxy- 
gen consumption 
rized in Table 1. None of these parameters was signifi- 
cantly different between oxygen pressures of 500 mmHg 
and 120 mmHg. It should be noted that the filtration 
fractions were relatively low (10.4_+ 0.9%, n = 5) because 
of the high perfusate flow rates observed under our ex- 
perimental conditions. 
In a second set of experiments we tested whether the 
increase of EPO production by the isolated perfused rat 
kidney upon lowering the oxygen pressure could be mim- 
icked by classic second-messenger molecules. We used 
forskolin (10 gM) and cyclic 8-bromo-GMP (100 gM) to 
increase cellular levels of cAMP and cGMP, respectively. 
Calmidazolium (1 gM) was taken to inhibit calmodulin 
activity [10]. All tested rugs were continuously and flow- 
proportionally infused into the arterial imb of the circu- 
lation for a 45-min period starting 30 min after the onset 
of perfusion. As shown in Fig. 3, forskolin (10 gM) and 
8-bromo-cGMP (100 gM) caused a slight but statistically 
not significant (P>0.05) decrease of EPO formation 
rates to 0.08 _+ 0.02 and 0.07 _+ 0.02 U h-  1 g-  1 respectively, 
when perfusion was performed at a PO 2 of 500 mmHg 
(n -- 3 for each condition). At the same time forskolin 
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Fig. 2. Relationship between erythropoietin (EPO) production rate in 
the isolated perfused rat kidney and oxygen pressure in the perfusate. 
EPO formation and arterial PO 2 values are inversely correlated in an 
almost linear fashion (regression curve, P<0.001). Values are means 
+SEM, n = 5 
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Fig. 3. Erythropoietin (EPO) production rates in the isolated perfused 
rat kidney obtained upon addition of forskolin (10 gM), 8-bromo- 
cGMP (100 p.M), and calmidazolium (1 IxM), respectively. The tested 
drugs were continuously infused into the arterial imb of the perfusion 
circuit for a 1-h period. Infusion was normally started 30 min after the 
onset of perfusion. Calmidazolium (1 gM) blunted the increase of EPO 
formation upon lowering arterial PO 2 from 500 mmHg to 120 mmHg 
(P < 0.01). Values are means +_ SEM; the number of experiments is indi- 
cated at the bottom of each bar 
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Table 3. Effect of calmidazolium on functional parameters of isolated 
rat kidneys perfused at PO 2 values of 120 mmHg 
Parameter Value after 
30 min 90 min 150 min 
Perfusion flow rate (ml min -  1 g -  1) 
Calmidazolium 12 -+ 1 12 _+1 12 -+ 1 
Control 10 _+2 11 _+2 13 -+3 
GFR (ml rain - ~ g -  I) 
Calmidazolium 1.3 -+0.2 1.1 _+0.1 1.0 -+0.2 
Control 1.2+0.1 1.3 _+0.1 1.3 +0.1 
Na reabsorption (% of tubular load) 
Calmidazolium 86 +4 69 +4 57 +4 
Control 93 +-1 76 _+4 59 _+3 
QO 2 (~tmol min -  1 g -  1) 
Calmidazolium 6.1 +_ 0.4 3.8 _+ 0.3 3.3 _+ 0.4 
Control 6.2 -+ 1.1 4.0 _+ 0.7 3.9 -+ 0.9 
a Functional parameters of isolated rat kidneys. At 45 min after the 
onset of perfusion, arterial PO 2 was lowered from 500mmHg to 
120mmHg. Calmidazolium (I gM) was continuously added for a 
45-min period starting 30min after the onset of perfusion. 
Calmidazolium was omitted in controls. Values are means+SEM,  
n=3 
and 8-bromo-cGMP decreased renal vascular esistance 
(Table 2). Moreover, the drop of oxygen consumption 
that appeared uring the course of the experiments (Ta- 
ble 1) was less pronounced in presence of forskolin, 
8-bromo-cGMP and calmidazolium. While calmidazoli- 
um had no significant effect on EPO release at an arterial 
PO2 of 500 mmHg it blunted the increase of EPO pro- 
Table 2. Effect of forskolin, 8-bromo-cGMP, and calmidazolium on 
isolated perfused rat kidneys a
Parameter Value after 
30 min 90 min 150 min 
Perfusion flow rate (ml min -  1 g -  l) 
Forskolin (10gM) 13 _+1 16 +_2* 13 _+ 2 
8-Bromo-cGMP (100gM) 15 _1 22 +1"  22 + 1" 
Calmidazolium (1 ~tM) 13 _+2 12 _+1 11 _+ 1 
GFR (ml ra in-  1 g -  ~) 
Forskolin (10gM) 1.3-+0.1 1.0-+0.1 0.9+ 0.1 
8-Bromo-cGMP (100~tM) 1.5_+0.1 1.3-+0.1 1.0-+ 0.1 
Calmidazolium (1 gM) 1.1 +0.2 1.2+_0.1 1.4 _+ 0.1 
Na reabsorption (~ of tubular load) 
Forskolin (10~tM) 73 +1 76 +_3 68 _+ i 
8-Bromo-cGMP (100~tM) 86 -+3 77 -+1 67 +_ 6 
Calmidazolium (1 ~tM) 90 -+ 2 77 -+ 7 67 +_ 12 
QO 2 (~tmol min -  1 g -  1) 
Forskolin (10~tM) 6.5+_0.1 6.6-+0.1 6.1-+ 0.1 
8-Bromo-cGMP (100~tM) 6.8_+0.3 6.2+0.6 5.7 + 0.2 
Calmidazolium (1 gM) 7.2-+0.3 6.7 +_0.1 6.1_+ 0.3 
a Kidneys were perfused at PO 2 values of 500 mmHg.  The tested drugs 
were continuously infused into the arterial imb of the circulation for 
a 45-min period starting 30 min after the onset of perfusion. Values are 
means _+ SEM, n = 3 for each condition 
* Significantly different from control (P<0.05) 
duction when the PO 2 was lowered from 500 to 
120 mmHg, without altering other functional parameters 
(Fig. 3, Table 3), in particular the oxygen consumption 
rates. W-7 (10 gM), a further putative calmodulin inhibi- 
tor, which structurally differs from calmidazolium [11], 
also prevented the rise of EPO formation at PO 2 values 
of 120mmHg (EPO production rate: 0.24_+0.07U h-1 
g- l ;  n =4). When forskolin (10~M) and 8-bromo- 
cGMP (100 gM) were applied at a PO 2 of 120 mmHg, 
EPO formation rates remained unchanged (1.1 _+0.1 and 
1.0+0.2 U h -1 g- l ,  respectively; n = 3 for each condi- 
tion). At the same time, forskolin (10 gM) and 8-bromo- 
cGMP (100gM) increased renal perfusate flow by 
52 + 3 ~ and 43 _+ 5 ~ of control values without affecting 
other functional parameters, uch as oxygen consump- 
tion. 
Discussion 
Our findings agree with and extend previous observations 
that the isolated perfused kidney releases erythropoietin 
(EPO) in an oxygen-dependent manner [7, 9, 16, 28]. Our 
data show that hypoxia-induced stimulation of EPO re- 
lease is a phenomenon that is not just restricted to isolat- 
ed perfused kidneys taken from hypoxic animals [7] but 
is also observed with kidneys taken from normoxic rats 
[9, 16, 28]. Since the normoxic rat kidney contains no 
stores for EPO [13] one can infer that the isolated perfus- 
ed rat kidney is capable of de novo synthesis of EPO. 
EPO formation by the isolated perfused rat kidney more- 
over displays some characteristics that are also observed 
in vivo. First, it is inversely proportional to renal oxygen 
supply (Fig. 2, [17]). Secondly, the time lag of 60-90 min 
between decrease of oxygen supply and increase of EPO 
release (Fig. 1) is similar to the period after which serum 
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EPO levels tart to increase upon hypoxia in vivo [17]. 
And finally, the maximal rate of EPO production, which 
is estimated tobe around 2 U h-lg kidney-1 in vivo [17], 
is comparable to the values calculated for the isolated 
perfused kidney. What differs in vivo is that the isolated 
perfused rat kidney stops producing EPO after 3 h of per- 
fusion. We think that this phenomenon results from a 
functional exhaustion of the preparation, because other 
parameters, uch as the sodium reabsorption rate and 
thereby the renal oxygen consumption, steadily decrease 
during the time of perfusion (Table 1). This functional 
deterioration is known to be a characteristic feature of 
kidneys perfused in vitro. Nevertheless, the continuous 
decrease of oxygen consumption, as particularly ob- 
served during perfusion at low PO2 values, was not rate- 
limiting for the hypoxia-induced laboration of EPO by 
the isolated perfused rat kidney. Thus, our findings sug- 
gest that the essentials of the oxygen sensor controlling 
EPO formation are predominantly located in the kidney 
itself. 
These data seem to be in contrast to the observation 
that selective reduction of oxygen supply to the kidneys 
by clamping of the renal arteries only causes a slight in- 
crease of the EPO formation rate, whereas lowering the 
systemic oxygen-transport capacity results in an exponen- 
tial rise of serum EPO levels [20]. It should be remem- 
bered, however, that reduction of renal perfusion flow 
not only causes a reduction of renal oxygen delivery but 
also decreases the tubular sodium load and thereby local- 
ly alters renal oxygen consumption [4]. 
The signal transduction process that links EPO for- 
mation to the oxygen supply has not yet been elucidated, 
and it appears as if the isolated perfused rat kidney could 
be a suitable model to study this process. Recently, it was 
reported that adenosine causes a twofold stimulation of 
EPO release from the isolated perfused rat kidney [21]. 
Since intrarenal levels of adenosine increase during insuf- 
ficient oxygen supply, it was suggested that adenosine 
could be a messenger molecule between oxygen supply 
and EPO production [8, 19, 22]. Cyclic AMP, cyclic GMP 
and calcium/calmodulin have also been suggested tohave 
a role in this signal transduction process [8]. To test for 
a possible involvement of cyclic nucleotides in the signal 
transduction process, we used forskolin and 8-bromo- 
cGMP to increase cellular levels of cAMP and cGMP, re- 
spectively. Both drugs significantly decreased renal vascu- 
lar resistance, but at the same concentrations either for- 
skolin nor 8-bromo-cGMP stimulated EPO production i  
kidneys perfused at PO2 values of 500 mmHg. Calmida- 
zolium, a putative calmodulin antagonist [10], also had 
no stimulatory effect on EPO formation at high PO 2 
values. 
It has been demonstrated that increasing cellular lev- 
els of cyclic AMP with forskolin had no effect on EPO 
formation in human hepatoblastoma (Hep G2) cells 
grown under normoxic onditions [27]. At the same time, 
however, forskolin further enhanced the stimulatory ef- 
fect of hypoxia on EPO secretion from Hep G2 cells ex- 
posed to an atmosphere of 1% oxygen [27]. Therefore, in 
the present study, we have also examined the effects of 
forskolin and 8-bromo-cGMP on EPO production i  iso- 
lated kidneys perfused under hypoxic conditions. Our 
finding that both drugs had no effect, in particular no 
additional stimulatory effect, on EPO production rates in 
isolated rat kidneys perfused at PO 2 values of 
120mmHg could indicate that the signal transduction 
mechanisms for EPO formation might not be principally 
the same in the human hepatoblastoma cell line Hep G2 
as in the intact kidney. 
Even more interesting might be our observation that 
the calmodulin antagonist calmidazolium blunted the in- 
crease of EPO formation when the oxygen pressure was 
lowered in the perfusate. This effect of calmidazolium 
was confirmed with W-7, another putative calmodulin i - 
hibitor [11], which structurally differs from calmidazoli- 
urn. Recently, evidence has been provided for a link be- 
tween the regulation of EPO production and proxi- 
mal-tubular energy consumption [6]. It might be conceiv- 
able, therefore, that calmodulin antagonists exert heir ef- 
fects by lowering the activity of the proximal tubular 
work. However, as compared to controls, calmidazolium 
and W-7 had no obvious side-effects on renal functional 
parameters, particularly not on sodium reabsorption and 
oxygen consumption. Moreover, since all of these drugs 
were constantly infused into the kidneys and at the same 
time continuously removed from the circulation by dialy- 
sis, it appears rather unlikely that the inhibitory action of 
calmidazolium and W-7 on hypoxia-induced EPO forma- 
tion was a toxic effect due to accumulation of the com- 
pounds. It seems possible, therefore, that a calmodulin- 
activated reaction is somehow involved in the oxygen-de- 
pendent EPO production. From the observation that 
calmidazolium and W-7 both blunted the increase of 
EPO formation induced by oxygen depletion whereas 
basal EPO production (at a PO 2 of 500 mmHg) re- 
mained nearly unaffected, one might infer that these 
drugs affect the oxygen-sensing mechanism rather than 
the synthesis and processing of EPO. The identification 
of this reaction step remains a task for future research. 
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